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AN EDUCATED PATIENT IS A SAFE PATIENT
Breen, A.W. Seattle Cancer Care Alliance, Seattle, WA.
The issues of limited medical literacy and patient anxiety are ad-
dressed in Seattle Cancer Care Alliance Patient and Family Educa-
tion program for bone marrow transplant recipients and caregivers.
Academic sophistication can not be a requirement for patient safety.
Instead, the Patient Centered, Patient and Family Caregiver Educa-
tion Program, utilizes a mix of teaching methods, learning opportu-
nities, information sources, and communication approaches to
facilitate caregiver role training and to impart patient knowledge.
Each step in the process emphasizes patient safety. Patient, care-
giver, and family education begins during the first contact with
our Center and continues after departure. Principles of social learn-
ing theory informed by a multiple intelligence approach are the ba-
sis for creating patient centered education. Orientation information
is available in various formats includingDVD,VHS, and interactive
web programming. Information is also offered in a pre-transplant
manual, coloring books, specialty booklet for teens, transplant
DVD, handouts, and classes. Formal 1:1 teaching sessions include
such topics as clinic orientation, line care, chemotherapy teaching,
and discharge/transition planning. Classes are also offered in key
topics such as Food Safety, Managing Care at Home, and Depar-
ture. Teaching methods include traditional lectures, role playing,
reviewing typical clinical scenarios, group discussions, and an exam-
ination of critical topics. Participants are quizzed orally or in writ-
ing. All elements of the program are routinely evaluated after each
class via a feedback section in the Patient Resource Manual, by Pa-
tient Advisors, and from patient questionnaires. Class ratings and
patient questionnaires are consistently high. The presentation will
include samples of the curriculum from the comprehensive pro-
gram,DVDs,manuals, and teaching content. An overview of the pa-
tient education trajectory from first contact to departure will be
presented. Program evaluation data and ongoing quality improve
initiatives will be shared.419
MAKING HEART SUCCESS: EDUCATING NURSES ABOUT A HEART FAIL-
URE PROGRAM
Knape, C.,Martin, A., Colleen, L., Ramos, J., Schuling, E., Granada,M.
The University of Texas MD Anderson Cancer Center, Houston, TX.
Oncology patients often have co-morbid conditions in addition
to their cancer diagnoses which the healthcare team must carefully
manage. One such condition is heart failure. A program called
Heart Success, an institutional multi-disciplinary program for heart
failure patients, is being trialed on an in-patient stem cell transplant/
cellular therapy unit. The Heart Success Program is in place to
identify, monitor, and educate patients who have heart failure
with the goals of improving clinical outcomes and quality of life
as well as decreasing lengths of stay and hospital admissions due
to heart failure exacerbation.
A unit-based Heart Success team comprised of selected clinical
nurses was created to provide the needed education for other nurs-
ing staff and to serve as super-users to whom other nurses can refer
for help enrolling and teaching patients in the program. Heart suc-
cess team members taught other clinical nurses on the in-patient
stem cell transplant unit the purpose of the Heart Success Program,
ways to identify patients who qualify for the program, instructions
for enrolling the patient, and appropriate teaching to provide the
patient and family. Team members conducted a ten minute in-ser-
vice for the clinical nurses on the unit and administered a pre and
post test to evaluate effectiveness of the teaching. An instructional
poster was created as a visual aid for the short in-service and was dis-
played on the unit for later reference.
Clinical nurses also learned how to use the Heart Success data
collection tool and document appropriately as well as how to partic-
ipate in bi-weekly meetings with cardiology representatives to dis-
cuss patients enrolled in the program. Heart Success teammembers remain visible on the unit to guide other nurses in Heart
Success activities.
Specific outcomes of staff nurse teaching and its impact on the ef-
fectiveness of the Heart Success Program in a stem cell transplant/
cellular therapy unit will be shared and discussed.
Clinical nurses play a unique and vital role in helping achieve the
Heart Success goals of identifying, monitoring, and educating pa-
tients who have heart failure.420
CHARACTERISTICS OF HSCT AND ONCOLOGY PATIENT FALLERS AND
THEIR FALLS IN AN AMBULATORY CANCER CENTER
Wickline, M.M. Seattle Cancer Care Alliance, Seattle, WA.
Patient falls are serious events that can cause death and loss of
function. HSCT and oncology patients have unique fall risk factors
and are often at high risk for injury when they do fall. Once thought
to be primarily an inpatient problem, we know that falls do occur in
outpatient centers where patient acuity and complexity of offered
therapies are increasing.
At the Seattle Cancer Care Alliance, we have tracked all reported
falls within our ambulatory care center since 2003. We have per-
formed an in-depth analysis of the characteristics of the fallers
and their falls in order to create and maintain the SCCAOutpatient
Fall Prevention Program. Our quarterly fall rates are between 0%-
0.07% (#falls/#patient visits), with a total of 65 falls (33 HSCT and
32 oncology patients) studied as of October 1, 2007.
HSCT patients who fell had higher incidence of anemia, throm-
bocytopenia, chronic steroid use and documented peripheral neu-
ropathy than the oncology patients who fell. Oncology patients
who fell had a higher incidence of bone metastases or bony involve-
ment than HSCT patients who fell. HSCT patients were more
likely to hit their head with a fall and more likely to sustain some
kind of injury than oncology patients. HSCT fallers had higher
harm scores (from Patient Safety Net on-line incident reporting)
attached to their falls than oncology patients.
Examining the characteristics of patient fallers and their falls has
been an important step in developing an Outpatient Fall Prevention
Program that is uniquely suited to our patient population.421
A RETROSPECTIVE ANALYSIS COMPARING THE DIRECT COSTS ASSOCI-
ATEDWITH THE USE OF G-CSF ALONE AND G-CSF AND CHEMOTHERAPY
IN STEM CELL MOBILIZATION
Wasko, M., Johnson, M., Sirilla, J. Ohio State University Arthur G.
James Cancer Hospital and Richard J. Solove Research Institute, Colum-
bus, OH.
According to the literature (Milone et al., 2003), G-CSF alone is
considered an adequate mobilization approach with no evidence of
a higher risk of neoplastic contamination and offers the advantage of
low cost, low morbidity and fast immune recovery.
A retrospective comparison was conducted to confirm research
findings of lower costs associated with the use of G-CSF alone ver-
sus the use of G-CSF and chemotherapy in stem cell mobilization.
The study provided practical evidence of the financial impact of the
two types of mobilization methods and provided validation for
changes in the standard of care within a large academic medical
center’s transplant program.
A descriptive study was performed using a convenience sample of
144 patientsmobilized with eitherG-CSF alone or withG-CSF and
chemotherapy. The investigation analyzed the following direct
costs: G-CSF, chemotherapy, lab work, blood transfusions, home
health care, apheresis procedures, stem cell laboratory processing,
central venous catheter (CVC) placement, CVC removal, IVPB
antibiotics, outpatient visits, inpatient hospitalizations, and pre-
transplant evaluations.
The study concurred with the literature that the use of G-CSF
alone offers the advantage of lower direct costs as compared with
G-CSF and chemotherapy in stem cell mobilization.
The study revealed an increase number of lymphoma patients
who, initially, failed mobilization with G-CSF alone; then, pro-
ceeded to collect stem cells successfully with G-CSF and
Poster Session II 151chemotherapy. Future implications for patients with lymphoma to
collect with G-CSF and chemotherapy are under consideration as
well as the utilization of the drug, AMD-3100 (AnorMED, Inc).422
EFFICACY OF MOUTH RINSES DURING CYTARABINE INFUSION IN
PREVENTING ORAL MUCOSITIS IN THE RECIPIENTS OF ALLOGENEIC
HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONED BY
HIGH-DOSE CYTARABINE AND TOTAL BODY IRRRADIATION
Hasegawa, K.1, Okabe, A.1, Kawada, Y.1, Tsujimura, N.1, Yashima, T.1,
Kobayashi, N.1, Kondo, S.1, Mori, T.2, Okamoto, S.2. 1Keio University
Hospital, Tokyo, Japan; 2Keio Univeristy School of Medicine, Tokyo,
Japan.
Background: Oral mucositis is one of the serious and frequent
conditioning-associated toxicities of allogeneic hematopoietic
stem cell transplantation (HSCT).We recently reported that cytar-
abine is excreted in the saliva after its high-dose administration, and
the cytarabine exreted in the saliva could play some role in causing
oral mucositis after HSCT (Anti-Cancer Drugs 2006; 17; 597).
Based on this finding, the efficacy of mouth rinses during cytarabine
infusion in preventing oral mucositis was prospectively evaluated in
allogeneic HSCT recipients treated with high-dose cytarabine.
Patients andMethods: Fifteen patients who underwent allogeneic
HSCT at Keio University Hospital between November 2006 and
June 2007 after being conditioned with TBI and high-dose cytara-
bine as described below were evaluated. Following TBI (12 Gy), cy-
tarabine at a dose of 3 g/m2 was administered intravenously over 2
hours every 12 hours for 4 consecutive days. Stem cells were bone
marrow from related (n 5 4) or unrelated (n 5 11) donor. Patients
were instructed to rinse their mouth with cold water every 10 min-
utes for 2 hours during cytarabine infusion and for additional 1 hour
after completion of cyrabine infusion. The grades of oral mucositits
were evaluated using National Cancer Institute Common Toxicity
Criteria (NCI-CTC) every day from the day of the first dose of cy-
tarabine to day 28 after HSCT and the maximum grade of each pa-
tient was considered as his or her grade.Results:The grades of oral
mucositis in 15 patients who performedmouth rinses wereGrade 0–
1 in 9 patients, and Grade 2 in 6 patients (40%): no patients devel-
opedGrade 3 oral mucositis. The grades of oral mucositis in control
patients receiving the same conditioning without mouth rinses (n5
35) were Grade 0–1 in 7, Grade 2 in 19 patients (54.3%), and Grade
3 in 9 patients (25.7%). Incidence of Grades 2–3 and Grade 3 oral
mucositis were significantly lower in patients who performedmouth
rinses as compared with control patients (40% vs. 80%; P5 0.009,
0% vs. 25.7%; P 5 0.02, respectively). Conclusion: Our findings
suggest that mouth rinses during cytarabine infusion could reduce
the incidence of oral mucositis caused by high-dose cytarabine. Al-
though this efficacy of mouth rinses is considered primarily due to
the removal of excreted cytarabine in the saliva, synergistic or addi-
tive effect of oral cryotherapy might contribute to the efficacy since
cold water was used for mouth rinses.423
LOWER LEGMUSCLE STRENGTH AND FATIGUE IN PATIENTS RECEIVING
HEMATOPOIETIC CELL TRANSPLANTATION UP TO TWOMONTHS AFTER
HOSPITAL DISCHARGE
Tonosaki, A. St Luke’s College of Nursing, Chuo-ku, Tokyo, Japan.
Purpose: To identify the factors relating to fatigue receiving
BMT up to two months after hospital discharge in order to provid
nursing care for early recovery.Method:The study was conducted
from November 2002 to November 2006. Sixty-six participants
were recruited at ResearchHospital of The Institute ofMedical Sci-
ence at Tokyo, Japan. Eligibility criteria for participation in the
study were: (1) more than 18 years old (2) scheduled for first time
transplantation (3) no uncontrolled hypertension, uncontrolled
pain, or unstable bone lesion. Approval was obtained from the ethics
committees at the hospital and authors’ belonging institution. Par-
ticipants were measured leg muscle strength (knee extension, ankle
plantar flexion, dorsiflexion strengths, and cross-sectional area ofthe thigh), State-Trait Anxiety Inventory (STAI-S) and Cancer Fa-
tigue Scale for Japanese (CFS). The measurement was performed
for 3 times, those were before entering the laminar air flow (LAF)
room, before hospital discharge and about two months after dis-
charge. In addition, steps per day was recorded by pedometer and
food intake data was collected from medical records. Multiple re-
gression analysis using stepwise regression (SPSS ver.14.0) was con-
ducted for factors relating to fatigue score after discharge. Result:
Twenty-five subjects who completed all 3 time-measurements
were examined. Twenty-two subjects had received cord blood
transplantation and three subjects had received BMT. The average
steps per day were 3304.8 (SD 1846.10) at twomonths after hospital
discharge. Post-transplantation days required to intake at least half
of meal portions (hereafter referred to as food intake recovery) was
91.1 (SD 42.21) days, and a significant correlation was noted be-
tween STAI-S and CFS for all points. Multiple regression analysis
demonstrated positive paths from food intake recovery (b5 .359;
P 5 .049) and average steps per day after discharge (b5 .357; P 5
.056) and negative path from ankle plantar flexion strength before
discharge (b5 -.435; P5 .020) to fatigue scores at two month after
discharge. Steps per day at after discharge was significantly corre-
lated with Cognitive domain in CFS after discharge (r 5 .566,
P 5 .003, n 5 25) Discussion: Results indicated that patients
may suffer from weakness during walking due to reduced muscle
strength in the ankle joints after transplantation. So preventive resis-
tance training should be started after early stage transplantation.424
PEDIATRIC PHERESIS LEG SPLINT IMMOBILIZATION TO INCREASE EFFI-
CIENCY OF STEM CELL COLLECTION AND CONTROL FEMORAL PHERE-
SIS CATHETER MALFUNCTIONS
Yocco, M., Healy, D., Barnes, Y., Chadakhtzian, A., Heidotten, A.,
Shenoy, S., Hayashi, R. St. Louis Chidren’s Hospital, St. Louis, MO.
Problem:Femoral pheresis cathetermafunction has been a recur-
ring problem in the infant to three year old population at St. Louis
Childrens Hospital. The very young pediatric patient would en-
counter problems with pheresis due to their inability to maintain
leg alignment during the procedure, resulting in kinked and ob-
structed femoral pheresis lines. The pheresis line malfunctions of-
ten require second pheresis line placement, increase cost and
length of hospital stay, increase sedation and sometimes result in
missing peak collection dates due to the line malfunction. Plan:
Prior to pheresis the patient was measured and a soft pheresis leg
splint was designed to immobilize the patients leg in which the phe-
resis catheter would be placed. The pheresis leg splint was placed on
the patient in the recovery room and remained in place until the
pheresis process was completed. Evaluation: The evaluation of
our experience with a active infant who underwent pheresis, while
utilizing the pheresis leg splint, was very positive. The patient re-
quired three days of pheresis to meet the stem cell goal and the
splint remained intact through out the process. The pheresis leg
splint maintained the proper alignment and pheresis was performed
without any catheter malfunctions. In the past it has been our expe-
rience that three days of pheresis in this age group would involve
multiple line complications and those issues made for a frustrating
pheresis experience for patient, family and healthcare providers.
Future Plans: A research study will be conducted with patients
from infant to three years of age using the pheresis leg splint and ret-
rospectively comparing a similar population of patients and their
pheresis outcomes. The catheter malfunction rate, cost and length
of hospital stay, sedation requirements and pheresis cell count will
be analyzed to determine the relevance of the pheresis leg splint
in the very young noncompliant pediatric patient population.425
IMPLEMENTATION OF A DEVELOPMENTAL FORM TO IMPROVE COM-
MUNICATION AND FOSTER CLINICAL DEVELOPMENT FOR THE BLOOD
AND MARROW TRANSPLANT NURSE AFTER THE ORIENTATION PERIOD
ENDS
Ellison, L.M. Stanford Hosptial and Clinics, Stanford, CA.
